| Patient | Nikola Tesla |
|---|---|
| Date of birth | 1856-07-10 |
| Identifiers | MRN HR-NI009-SYN-TD; SSN (made up) 000-09-7408 |
| Document date | 1902-04-07 |
| Author | Branimir Kovač-Holt, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Twelve-week OCD treatment review. [S]
Mr. Tesla returns twelve weeks after starting sertraline and six weeks after the increase to 100 mg. At the nurse telephone check two weeks after the increase he reported two days of loose stools and no other side effects, and he has missed no doses. He has had eleven ERP sessions. He washes about 12 times a day, shook hands with an investor last week, and eats most meals without calculating. Counting steps and repeating actions in threes still take about an hour a day. His hands have healed. He sleeps about five and a half hours. He has had no suicidal thoughts. [S]
| Element | Detail |
|---|---|
| Interval change | Washing about 12 times a day; shook hands with an investor; most meals without calculating |
| Psychotherapy | Eleven ERP sessions |
| Rituals | About an hour a day of counting and repeating |
| Hands | Healed |
| Safety | No suicidal thoughts |
| Y-BOCS | 19, down from 28 |
| System | Result | Finding |
|---|---|---|
| Gastrointestinal | Negative | Two days of loose stools after the increase; none now |
| Integumentary | Negative | Hands healed |
| Psychiatric | Positive | Counting and repeating still present; mood better; no suicidal thoughts |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 1902-01-13 to 1902-02-24 | completed | S |
| Sertraline 100 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 1902-02-24 to 1902-04-07 | completed | S |
| Sertraline 50 mg oral tablet, three tablets (150 mg) by mouth each morning | Three tablets by mouth each morning | Oral route | 1902-04-07 | active | S |
| White petrolatum ointment, apply to both hands after each wash and at bedtime | Apply a thin layer to both hands after washing and at bedtime | Topical route | 1902-01-13 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1902-04-07 | Body height | 188 | cm | S |
| 1902-04-07 | Body weight | 65.2 | kg | S |
| 1902-04-07 | Body mass index (BMI) [Ratio] | 18.4 | kg/m2 | S |
| 1902-04-07 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1902-04-07 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1902-04-07 | Heart rate | 68 | /min | S |
| 1902-04-07 | Respiratory rate | 14 | /min | S |
| 1902-04-07 | Body temperature | 36.6 | Cel | S |
| 1902-04-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Vital signs recorded on 1902-04-07; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Slim; relaxed |
| Skin | Examined with his agreement: skin of both hands intact, without redness or fissures |
| Mental status | Engaged and wry; mood "much freer"; affect reactive; good insight; no suicidal ideation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Obsessive-compulsive disorder, severe (Y-BOCS 28), with good insight: contamination, symmetry, and number obsessions; washing, counting, repeating in threes, and calculating compulsions; synthetic modern diagnosis linked to his own accounts of counting and calculating rituals and aversions | active | confirmed | F42.2 | S — Synthetic modern diagnosis. His rituals and aversions are documented in his own words (D); calling them obsessive-compulsive disorder is a retrospective interpretation (R), and no diagnosis was made in his lifetime. |
| Irritant contact dermatitis of both hands from washing them 40 to 60 times a day | resolved | confirmed | L24.9 | S — Synthetic consequence of washing compulsions. |
| Underweight (BMI 18.1) with about 4 kg weight loss over six months, from skipped meals and food-calculating rituals | active | confirmed | R63.6 | S — Synthetic nutritional consequence echoing his documented habit of calculating the volume of food before eating. |
| Insufficient sleep, four hours a night, from late work and night-time rituals | active | confirmed | Z72.820 | S — Synthetic sleep problem echoing his documented claims about very short sleep. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Y-BOCS severity score (recorded in the note; no LOINC code found) | At baseline and about every 4 to 6 weeks during acute treatment | Completed today | 19, down 32 percent from 28: partial response; dose increased to 150 mg |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9 when given) | Every visit during acute treatment | Completed today | No suicidal thoughts, intent, plan, or behavior since the last visit. Safety plan reviewed |
| Medication safety | Sertraline adherence and adverse effects (nausea, diarrhea, sleep, activation, sexual effects) | Every visit and two weeks after each dose increase | Completed today | Nurse call two weeks after the last increase: two days of loose stools; no missed doses; dose increased to 150 mg with a nurse call in two weeks |
| Self-management | Exposure and response prevention attendance and homework | Every visit during acute treatment | Completed today | Eleven sessions; handshake and most meals without calculating |
| Examination | Weight and BMI | Every visit while underweight | Completed today | 65.2 kg, BMI 18.4 |
| Examination | Hand skin | Every visit while dermatitis is present | Completed today | Healed |
| Self-management | Sleep diary | Every visit during acute treatment | Completed today | About five and a half hours a night |
| Medication safety | Antipsychotic augmentation monitoring (weight, glucose, lipids, movement) | Only if an antipsychotic is added | Not indicated | No augmentation; responding to sertraline and ERP |
Goal progress:
Guideline basis: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2007); Guideline Watch: Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder (2013); Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31) (2005); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)
Follow-up: Nurse telephone check in two weeks; review in twelve weeks, after at least eight weeks at 150 mg. Next scheduled visit 1902-06-30: twenty-four-week OCD treatment review. [S]